Press releases

Atrial Fibrillation Burden: New Consensus Definition Aims to Improve Care and Research

An international panel of experts led by Prof. Dr. Wolfram Döhner (Charité and DZHK) has introduced a standardized definition of atrial fibrillation…

Read more

New junior research group investigates how the immune system responds to stress and its potential impact on cardiovascular health

At the LMU University Hospital in Munich, Dr Kami Alexander Pekayvaz is launching a new junior research group. His research focuses on the connection…

Read more

European funders commit over €5 million for research into heart and circulatory diseases

Leading mid-career researchers in France, Germany, the Netherlands and the UK are uniting to drive innovations in detecting, diagnosing and treating…

Read more

New therapeutic approach: synthetic peptide improves cardiac performance

A synthetic peptide called S100A1ct significantly improves heart function and increases the survival rate in preclinical models, according to a recent…

Read more

Loss of the Y chromosome discovered as a new risk factor for heart disease

Men who lose their Y chromosome in part of their blood cells have an increased risk of cardiovascular disease - in particular a fatal heart attack.…

Read more

Patented therapeutic approach could prevent severe heart damage after a heart attack

A new therapeutic approach could help millions of patients to prevent the late effects of a heart attack - the excess formation of scar tissue. Philip…

Read more

Artificial intelligence detects heart aging in ECG and provides early warning of cardiovascular risks.

An interdisciplinary research team from the German Centre for Cardiovascular Research (DZHK) has demonstrated for the first time in a long-term…

Read more

DZHK research paves the way for ‘heart patch’ therapy in heart failure

Successful preclinical testing in an animal model enables the world's first treatment of patients with heart tissue cultivated from stem cells. The…

Read more

Treating cardiomyopathies: DZHK and Bristol Myers Squibb collaborate to evaluate real-world data

The aim of the research collaboration is to optimise the treatment of hypertrophic obstructive cardiomyopathy and adapt it to the individual needs of…

Read more

Immunological processes in atrial fibrillation: 8 million dollars for research on disease mechanism

A team of researchers from the DZHK Munich site, together with colleagues from the USA, France and the Netherlands, has received funding from the…

Read more